Thras Kayardis: AI Revolution in Drug Discovery & DeepCure's Innovative Future

Ideagen Radio

Join us as we unravel the fascinating journey of Thrasyvoulos Karydis, or Thras, the brilliant mind behind DeepCure's technological revolution in drug discovery. From the serene landscapes of Corfu, Greece, to the bustling halls of MIT, Thras's path is a testament to the power of curiosity and innovation. With a robust background in electrical engineering, computer science, and physics, Thras ventured into the biotechnological frontier, merging AI with molecular biology to spearhead groundbreaking advancements in immunology and inflammation treatments. Discover how his transformative experiences at the MIT Media Lab ignited the spark that would become DeepCure, a company at the cutting edge of therapeutic development.
In our conversation, we explore the synergetic power of AI and human expertise in overcoming the traditional constraints of drug design. Thras shares real-life narratives of initial challenges turning into triumphs, illustrating AI's potential to reshape the landscape of drug discovery. Thras discusses DeepCure's ambitious goals, including upcoming clinical trials for DC9476 targeting rheumatoid arthritis. As DeepCure continues to push boundaries with their innovative platform and open-minded approach, find out how they plan to repeatedly design transformative therapeutics and make a lasting impact on patient lives. Don't miss this insightful episode that promises a glimpse into the future of healthcare innovation.
#ideagenglobal #globalpartnerships #deepcure
Thras's LinkedIn: https://www.linkedin.com/in/thkarydis/
Learn more about DeepCure here: https://www.deepcure.ai/
Watch the entire Global Partnerships Summit here: https://www.ideagenglobal.com/2024-global-partnerships-summit

챕터

1. Thras Kayardis: AI Revolution in Drug Discovery & DeepCure's Innovative Future (00:00:00)

2. Innovative Solutions for Inflammation (00:00:12)

3. AI in Drug Discovery and Partnerships (00:13:55)

4. The Future of DeepCure (00:25:11)